Mobile Logo in White

CancerNetwork: Rhenium Obisbemeda Shows No DLTs and Improves Survival in Recurrent Glioma

Andrew J. Brenner, MD, PhD, professor and chair of neuro-oncology research at the Mays Cancer Center at UT Health San Antonio, was featured in this video.

 

Watch Now

 

 

 



Share This Article!
Categories:
Secured By miniOrange